Enhanced PeriOperative Care and Health protection programme for the prevention of surgical site infections after elective abdominal surgery (EPOCH): study protocol of a randomised controlled, multicentre, superiority trial. Issue 5 (25th May 2020)

• Record Type: Journal Article
• Authors: de Jonge, Stijn W; Wolfhagen, Niels; Boldingh, Quirine JJ; Bom, Wouter J; Posthuma, Linda M; Scheijmans, Jochem CG; van der Leeuw, Bart MF; van der Hoeven, Joost AB; Hering, Jens Peter; Sonneveld, Dirk JA; van Geffen, Otto E; Hendriks, Eduard R; Kluyver, Ewoud B; Demirkiran, Ahmet; van Lonkhuijzen, Luc RCW; Slotema, Thomas; Draaisma, Werner A; Koopman, Seppe JSHA; van Rossem, Charles C; Over, Linda M; van Duijvendijk, Peter; Dijkgraaf, Marcel GW; Hollmann, Markus W; Boermeester, Marja A
• Is Part Of: BMJ open. Volume 10:Issue 5(2020)
• Publication Date: 2020-05-25
• Subjects: adult surgery -- adult anaesthesia -- preventive medicine -- wound management; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-038196
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Surgical site infections (SSI) are a common postoperative complication. During the development of the new WHO guidelines on SSI prevention, also in the Netherlands was concluded that perioperative care could be optimised beyond the current standard practice. We selected a limited set of readily available, cheap and evidence-based interventions from these new guidelines that are not part of standard practice in the Netherlands and formulated an Enhanced PeriOperative Care and Health bundle (EPOCH). Here, we describe the protocol for an open-label, randomised controlled, parallel-group, superiority trial to test the effect of the EPOCH bundle added to (national) standard care in comparison to standard care alone on the incidence of SSI. Methods and analysis: EPOCH consists of intraoperative high fractional inspired oxygen (0.80); goal-directed fluid therapy; active preoperative, intraoperative and postoperative warming; perioperative glucose control and treatment of severe hyperglycaemia (>10 mmol l-1 ) and standardised surgical site handling. Patients scheduled for elective abdominal surgery with an incision larger than 5 cm are eligible for inclusion. Participants are randomised daily, 1:1 according to variable block sizes, and stratified per participating centre to either EPOCH added to standard care or standard care only. The primary endpoint will be SSI incidence according to the Centers for Disease Control and Prevention (CDC) definition within 30 days as part of routine clinical follow-up. Four additional questionnaires will be sent out over the course of 90 days to capture disability and costs. Other secondary endpoints include anastomotic leakage, incidence of incisional hernia, serious adverse events, hospital readmissions, length of stay and cost effectiveness. Analysis of the primary endpoint will be on an intention-to-treat basis. Ethics and dissemination: Ethics approval is granted by the Amsterdam UMC Medical Ethics Committee (reference 2015_121). Results will be disseminated through peer-reviewed journals and summaries shared with stakeholders. This protocol is published before analysis of the results. Trial registration number: Registered in the Dutch Trial Register: NL5572.